A new tool to screen drugs that target loss of tumor suppressor genes

by Ludwig Cancer ResearchGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.104437In a May publication iniScience, researchers led by Ludwig Johns Hopkins's

Updated on: January 30,2024

A new tool to screen drugs that target loss of tumor suppressor genes

by Ludwig Cancer ResearchGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.104437In a May publication iniScience, researchers led by Ludwig Johns Hopkins's

Updated on:January 30,2024

Study shows 'feasibility' of ending specialist follow-up in patients with low-risk chronic lymphocytic leukemia

by American Society of HematologyCredit: CC0 Public DomainA study published inBlood Advancesshowed that among patients in Denmark who had slow-growing chronic lymphocytic leukemia (CL

Updated on: April 06,2024

Study shows 'feasibility' of ending specialist follow-up in patients with low-risk chronic lymphocytic leukemia

by American Society of HematologyCredit: CC0 Public DomainA study published inBlood Advancesshowed that among patients in Denmark who had slow-growing chronic lymphocytic leukemia (CL

Updated on:April 06,2024

Study suggests a way to re-energize tired T cells when treating cancer, viral infections

by Ohio State University Medical CenterScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDA new study by researche

Updated on: February 20,2024

Study suggests a way to re-energize tired T cells when treating cancer, viral infections

by Ohio State University Medical CenterScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDA new study by researche

Updated on:February 20,2024

Reprograming T cells to attack solid tumors

by Agency for Science, Technology and Research (A*STAR), SingaporeA colourful battle: Live human liver cancer cells (green) are attacked by engineered T cells (blue), resulting in a dead liver ca

Updated on: April 07,2024

Reprograming T cells to attack solid tumors

by Agency for Science, Technology and Research (A*STAR), SingaporeA colourful battle: Live human liver cancer cells (green) are attacked by engineered T cells (blue), resulting in a dead liver ca

Updated on:April 07,2024

AI in personalized cancer medicine: New therapies require flexible and safe approval conditions

by Viktoria Bosak,Dresden University of TechnologyA perspective on the US and EU regulatory system readiness for AI-enabled personalized drug and cell-based therapies in precision oncology. The

Updated on: March 05,2024

AI in personalized cancer medicine: New therapies require flexible and safe approval conditions

by Viktoria Bosak,Dresden University of TechnologyA perspective on the US and EU regulatory system readiness for AI-enabled personalized drug and cell-based therapies in precision oncology. The

Updated on:March 05,2024

Study identifies novel epigenetic changes in pediatric brain cancer

by Melissa Rohman,Northwestern UniversityDNA methylation and transcriptomic landscape of recurrent ependymoma tumors. A Time-course summary of surgery, radio- and chemotherapy treatment and tumo

Updated on: February 23,2024

Study identifies novel epigenetic changes in pediatric brain cancer

by Melissa Rohman,Northwestern UniversityDNA methylation and transcriptomic landscape of recurrent ependymoma tumors. A Time-course summary of surgery, radio- and chemotherapy treatment and tumo

Updated on:February 23,2024

Brain boost: Can a coach help elders at risk for Alzheimer's?

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainAs more medications move towards federal approval for Alzheimer's disease, a new study led by researchers at UC San

Updated on: April 18,2024

Brain boost: Can a coach help elders at risk for Alzheimer's?

by University of California, San FranciscoCredit: Unsplash/CC0 Public DomainAs more medications move towards federal approval for Alzheimer's disease, a new study led by researchers at UC San

Updated on:April 18,2024

Novel classification can lead to new ways to diagnose and treat cancer

by Baylor College of MedicineDr. Chad Creighton is the first author of this work. Credit: Baylor College of MedicineA novel approach to studying cancer has enabled researchers to group about 10,0

Updated on: March 01,2024

Novel classification can lead to new ways to diagnose and treat cancer

by Baylor College of MedicineDr. Chad Creighton is the first author of this work. Credit: Baylor College of MedicineA novel approach to studying cancer has enabled researchers to group about 10,0

Updated on:March 01,2024

Private and secure generative AI tool supports operations and research in a cancer center

byDana-Farber Cancer InstituteCredit: CC0 Public DomainDana-Farber Cancer Institute has implemented an artificial intelligence (AI) application intended for general use in a medical center or ho

Updated on: March 30,2024

Private and secure generative AI tool supports operations and research in a cancer center

byDana-Farber Cancer InstituteCredit: CC0 Public DomainDana-Farber Cancer Institute has implemented an artificial intelligence (AI) application intended for general use in a medical center or ho

Updated on:March 30,2024

Genomic screening can help detect thyroid cancer, finds study

byGeisinger Health SystemCredit: Pixabay/CC0 Public DomainPopulation-based genomic screening can facilitate early detection of medullary thyroid cancer (MTC) in patients with variants in the RET

Updated on: January 23,2024

Genomic screening can help detect thyroid cancer, finds study

byGeisinger Health SystemCredit: Pixabay/CC0 Public DomainPopulation-based genomic screening can facilitate early detection of medullary thyroid cancer (MTC) in patients with variants in the RET

Updated on:January 23,2024

AZD1390 with radiotherapy shows manageable safety profile and preliminary efficacy for patients with glioblastoma

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAZD1390, an ataxia telangiectasia mutant (ATM) kinase inhibitor, demonstrated a manageable safety profile in both recur

Updated on: April 28,2024

AZD1390 with radiotherapy shows manageable safety profile and preliminary efficacy for patients with glioblastoma

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAZD1390, an ataxia telangiectasia mutant (ATM) kinase inhibitor, demonstrated a manageable safety profile in both recur

Updated on:April 28,2024

Lactate-producing bacteria inside tumors found to promote resistance to radiation therapy

by University of Texas M. D. Anderson Cancer CenterGraphical Abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.09.012Researchers at The University of Texas MD Anderson Can

Updated on: April 09,2024

Lactate-producing bacteria inside tumors found to promote resistance to radiation therapy

by University of Texas M. D. Anderson Cancer CenterGraphical Abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.09.012Researchers at The University of Texas MD Anderson Can

Updated on:April 09,2024